ZA835326B - Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same - Google Patents
Analgesic and anti-inflammatory compositions comprising caffeine and methods of using sameInfo
- Publication number
- ZA835326B ZA835326B ZA835326A ZA835326A ZA835326B ZA 835326 B ZA835326 B ZA 835326B ZA 835326 A ZA835326 A ZA 835326A ZA 835326 A ZA835326 A ZA 835326A ZA 835326 B ZA835326 B ZA 835326B
- Authority
- ZA
- South Africa
- Prior art keywords
- caffeine
- analgesic
- methods
- same
- inflammatory compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40059782A | 1982-07-22 | 1982-07-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA835326B true ZA835326B (en) | 1984-09-26 |
Family
ID=23584242
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA835326A ZA835326B (en) | 1982-07-22 | 1983-07-21 | Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same |
| ZA835324A ZA835324B (en) | 1982-07-22 | 1983-07-21 | Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA835324A ZA835324B (en) | 1982-07-22 | 1983-07-21 | Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same |
Country Status (15)
| Country | Link |
|---|---|
| JP (3) | JPS59501459A (en) |
| AT (2) | AT389226B (en) |
| AU (1) | AU558485B2 (en) |
| BE (1) | BE897356A (en) |
| CA (1) | CA1217429A (en) |
| CH (1) | CH659391A5 (en) |
| DE (1) | DE3390116C2 (en) |
| FR (1) | FR2530469A1 (en) |
| GB (1) | GB2134786B (en) |
| IE (1) | IE55367B1 (en) |
| IT (1) | IT1206502B (en) |
| NL (1) | NL191432C (en) |
| SE (1) | SE466481B (en) |
| WO (1) | WO1984000488A1 (en) |
| ZA (2) | ZA835326B (en) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4559343A (en) * | 1982-09-07 | 1985-12-17 | Alcon Laboratories, Inc. | Nonirritating aqueous ophthalmic compositions comfort formulation for ocular therapeutic agents |
| US4567183A (en) * | 1983-03-11 | 1986-01-28 | Analgesic Associates | Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same |
| US4558051A (en) * | 1983-10-11 | 1985-12-10 | Richardson-Vicks, Inc. | Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same |
| CH664085A5 (en) * | 1985-02-08 | 1988-02-15 | Ciba Geigy Ag | PHARMACEUTICAL PREPARATIONS WITH ANALGETIC EFFECTIVENESS AND THEIR PRODUCTION. |
| CH669523A5 (en) * | 1986-06-25 | 1989-03-31 | Mepha Ag | |
| GB8626098D0 (en) * | 1986-10-31 | 1986-12-03 | Euro Celtique Sa | Controlled release hydromorphone composition |
| US20040115290A1 (en) | 2001-06-20 | 2004-06-17 | Tripp Matthew L. | Modulation of inflammation by hops fractions and derivatives |
| US8329216B2 (en) | 2001-07-06 | 2012-12-11 | Endo Pharmaceuticals Inc. | Oxymorphone controlled release formulations |
| WO2003004030A1 (en) | 2001-07-06 | 2003-01-16 | Endo Pharmaceuticals, Inc. | Oxymorphone controlled release formulations |
| US8158160B2 (en) | 2001-11-13 | 2012-04-17 | Eric Hauser Kuhrts | Anti-inflammatory cyclooxygenase inhibitors |
| US7914831B2 (en) * | 2004-02-27 | 2011-03-29 | Metaproteomics, Llc | Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines |
| JP2006282644A (en) * | 2005-04-05 | 2006-10-19 | Idemitsu Kosan Co Ltd | Fatigue recovery agent |
| TW201247195A (en) * | 2011-04-28 | 2012-12-01 | Kowa Co | Stable pharmaceutical composition |
| JP2022105704A (en) * | 2016-10-31 | 2022-07-14 | エスエス製薬株式会社 | Pharmaceutical composition |
| JP2021054728A (en) * | 2019-09-27 | 2021-04-08 | 興和株式会社 | Pharmaceutical |
| JP6811453B1 (en) * | 2020-06-24 | 2021-01-13 | 医療法人すぎやま内科 | Composition for transdermal absorption |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3439094A (en) * | 1967-07-20 | 1969-04-15 | Warner Lambert Pharmaceutical | Analgesic compositions containing namol xenyrate,caffeine and acetyl-rho-aminophenol |
| US4049803A (en) * | 1976-04-26 | 1977-09-20 | Bristol-Myers Company | Augmentation of blood levels of aspirin |
| JPS5423132A (en) * | 1977-07-19 | 1979-02-21 | Dai Ichi Seiyaku Co Ltd | Analgesic composition |
| JPS54154416A (en) * | 1978-05-26 | 1979-12-05 | Tdk Electronics Co Ltd | High dielectric constant porcelain composition |
| US4233315A (en) * | 1978-12-18 | 1980-11-11 | Mcneilab, Inc. | Analgesic potentiation |
| US4234601A (en) * | 1978-12-18 | 1980-11-18 | Mcneilab, Inc. | Analgesic potentiation |
| US4233317A (en) * | 1978-12-18 | 1980-11-11 | Mcneilab, Inc. | Analgesic potentiation |
| US4233314A (en) * | 1978-12-18 | 1980-11-11 | Mcneilab, Inc. | Analgesic potentiation |
| US4233316A (en) * | 1978-12-18 | 1980-11-11 | Mcneilab, Inc. | Analgesic potentiation |
| US4237140A (en) * | 1979-05-18 | 1980-12-02 | E. I. Du Pont De Nemours And Company | Analgesic mixture of nalbuphine and acetaminophen |
| US4315936A (en) * | 1979-12-17 | 1982-02-16 | Ortho Pharmaceutical Corporation | Analgesic composition |
| JPS56154416A (en) * | 1980-04-30 | 1981-11-30 | Kaken Pharmaceut Co Ltd | Antipyretic analgesic composition |
| US4322427A (en) * | 1981-04-16 | 1982-03-30 | Bristol-Myers Company | Analgetic compositions and methods of use |
| US4420483A (en) * | 1982-07-22 | 1983-12-13 | Richardson-Vicks, Inc. | Analgesic and anti-inflammatory compositions comprising ibuprofen and methods of using same |
-
1983
- 1983-07-21 AU AU18816/83A patent/AU558485B2/en not_active Expired
- 1983-07-21 NL NL8320240A patent/NL191432C/en not_active IP Right Cessation
- 1983-07-21 JP JP58502643A patent/JPS59501459A/en active Pending
- 1983-07-21 IE IE1715/83A patent/IE55367B1/en not_active IP Right Cessation
- 1983-07-21 ZA ZA835326A patent/ZA835326B/en unknown
- 1983-07-21 CH CH1546/84A patent/CH659391A5/en not_active IP Right Cessation
- 1983-07-21 DE DE3390116T patent/DE3390116C2/en not_active Expired - Lifetime
- 1983-07-21 CA CA000432886A patent/CA1217429A/en not_active Expired
- 1983-07-21 ZA ZA835324A patent/ZA835324B/en unknown
- 1983-07-21 WO PCT/US1983/001121 patent/WO1984000488A1/en active Application Filing
- 1983-07-21 AT AT0903983A patent/AT389226B/en not_active IP Right Cessation
- 1983-07-21 JP JP58502781A patent/JPS59501460A/en active Pending
- 1983-07-21 FR FR8312109A patent/FR2530469A1/en active Pending
- 1983-07-21 GB GB08406704A patent/GB2134786B/en not_active Expired
- 1983-07-21 IT IT8322173A patent/IT1206502B/en active
- 1983-07-22 BE BE0/211220A patent/BE897356A/en unknown
-
1984
- 1984-03-20 SE SE8401538A patent/SE466481B/en not_active IP Right Cessation
-
1988
- 1988-10-05 AT AT0245988A patent/AT389998B/en not_active IP Right Cessation
-
1994
- 1994-07-18 JP JP6165470A patent/JPH07165583A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IT1206502B (en) | 1989-04-27 |
| NL191432B (en) | 1995-03-01 |
| DE3390116C2 (en) | 1994-06-16 |
| WO1984000488A1 (en) | 1984-02-16 |
| IE831715L (en) | 1984-01-22 |
| ATA903983A (en) | 1989-04-15 |
| ATA245988A (en) | 1989-08-15 |
| FR2530469A1 (en) | 1984-01-27 |
| BE897356A (en) | 1983-11-14 |
| JPS59501460A (en) | 1984-08-16 |
| IE55367B1 (en) | 1990-08-29 |
| JPH07165583A (en) | 1995-06-27 |
| AU558485B2 (en) | 1987-01-29 |
| CA1217429A (en) | 1987-02-03 |
| NL191432C (en) | 1995-07-04 |
| AT389998B (en) | 1990-02-26 |
| AT389226B (en) | 1989-11-10 |
| GB2134786A (en) | 1984-08-22 |
| SE466481B (en) | 1992-02-24 |
| SE8401538D0 (en) | 1984-03-20 |
| CH659391A5 (en) | 1987-01-30 |
| NL8320240A (en) | 1984-06-01 |
| GB8406704D0 (en) | 1984-04-18 |
| GB2134786B (en) | 1986-05-08 |
| SE8401538L (en) | 1984-03-20 |
| ZA835324B (en) | 1984-09-26 |
| IT8322173A0 (en) | 1983-07-21 |
| DE3390116T1 (en) | 1985-01-10 |
| JPS59501459A (en) | 1984-08-16 |
| AU1881683A (en) | 1984-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2161076B (en) | Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same | |
| ZA849680B (en) | Analgesic and anti-inflammatory compositions comprising xanthine and methods of using same | |
| GB2162747B (en) | Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same | |
| ZW20383A1 (en) | Compounds compositions and methods of use therefor | |
| DE3372705D1 (en) | Pharmaceutical composition and its use | |
| GB2134786B (en) | Improved analgesic and anti-inflammatory compositions comprising caffeine and methods of using same | |
| GB2132891B (en) | Improved analgesic and anti-inflammatory compositions comprising ibuprofen and method of using same | |
| GB2182323B (en) | Settable compositions and methods of use thereof | |
| AU8258282A (en) | Analgesic compositions and methods of use | |
| PH17898A (en) | Analgesic mixture of nalsuphine and isuprofen | |
| PH19352A (en) | Fluoromethylthiooxacephalosporins derivatives compositions containing same and method of use thereof | |
| GB2113338B (en) | Grouting composition and method of using same | |
| GB2160893B (en) | Soldering compositions and methods of use | |
| NZ205732A (en) | Thiatriazine derivatives and pharmaceutical compositions | |
| GB8319146D0 (en) | Formulations of vinca alkaloids | |
| NZ203649A (en) | 2-beta-d-ribofuranosylselenazole-4-carboxamide derivatives and pharmaceutical compositions | |
| GB2123417B (en) | Preparation and use of metal dithiobenzoates | |
| DE3261724D1 (en) | Analgesic and anti-inflammatory composition | |
| PH17913A (en) | Analgesic mixture of nalbuphine and flurbiprofen | |
| DE3276871D1 (en) | Preparation of 6-deoxy-d-fructose and 6-deoxy-l-sorbose | |
| PH21826A (en) | N-aryl-n(-piperidinyl)-alkoxyalkylamides and pharmaceutical compositions and methods of use employing such compounds | |
| ZA835081B (en) | Formulations of vinca alkaloids | |
| PH17118A (en) | Antihypertensive pharmaceutical compositions and its method of use | |
| PT76389B (en) | Process for the preparation of 7-alpha-aminoacyl-3-chlorocepha-losporins having and anti-infections effect and their use for the preparation of pharmaceutical compositions having an anti-infections effect | |
| PH16339A (en) | Dermatological compositions and method of use thereof |